Cabaletta Bio CABA
NASDAQ CABA
$1.87 -0.05 (-2.86%)
As of: Oct 1, 2026 · 2:15 PM EDT

Cabaletta Bio (CABA) Accumulated Depreciation (2019 - 2025)

Updated

Cabaletta Bio (CABA) recorded Accumulated Depreciation of $7.15 million in Q4 2025, up 29.9% from $5.51 million a year earlier.

Analysis

Cabaletta Bio (CABA) Accumulated Depreciation (2019 - 2025) Analysis & Trends

Starting with Q4 2019, Cabaletta Bio's Accumulated Depreciation history includes 7 quarters.

  • Annual Accumulated Depreciation has increased for six straight years, with a five-year compound annual growth rate of 73.3% (FY2020 to FY2025).
  • Across earlier years, Accumulated Depreciation came in at $5.51 million in FY2024 (+45.1%), $3.8 million in FY2023 (+60.2%), $2.37 million in FY2022 (+98.9%) and $1.19 million in FY2021 (+160.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cabaletta Bio 325.53 Mn 325.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.15 Mn
Dec 31, 2024 5.51 Mn
Dec 31, 2023 3.80 Mn
Dec 31, 2022 2.37 Mn
Dec 31, 2021 1.19 Mn
Dec 31, 2020 458,000.00
Dec 31, 2019 104,000.00
API Access

Cabaletta Bio Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=CABA&period=max&api_key=YOUR_API_KEY